Results 101 to 110 of about 493,523 (218)
Hypertrophic cardiomyopathy can be accompanied by dynamic obstruction in the left ventricular outflow tract and acute apical ballooning, which are among the very rare causes of cardiogenic shock. This condition requires a specific treatment approach that
Matej Strycek +3 more
doaj +1 more source
Cardiogenic shock and nutrition: safe? [PDF]
Cardiogenic shock is a common diagnosis in patients in the intensive care unit (ICU), and is characterized by a decreased cardiac output in the presence of adequate intravascular volume associated with an inadequate tissue perfusion including a ...
Pichard, Claude +3 more
core
Heart failure medication to prevent cancer therapy–related cardiac dysfunction: A narrative review
Advances in oncological therapies have improved cancer survival but also have increased the clinical incidence of cancer therapy–related cardiac dysfunction (CTRCD), a spectrum of conditions ranging from subclinical biomarker or strain abnormalities to progressive heart failure and cardiogenic shock.
Fabian Voß +3 more
wiley +1 more source
Abstract Background We compared characteristics of adults with insulin‐treated diabetes using continuous subcutaneous insulin infusion (CSII) versus multiple daily insulin injections (MDI) during admission with acute coronary syndrome (ACS) and identified factors associated with in‐hospital mortality among CSII users.
Harshal Deshmukh +6 more
wiley +1 more source
Biomarkers in cardiogenic shock: old pals, new friends
In cardiogenic shock, biomarkers should ideally help make the diagnosis, choose the right therapeutic options and monitor the patient in addition to clinical and echocardiographic indices.
Mathieu Jozwiak +3 more
doaj +1 more source
ABSTRACT Introduction In patients with ischemic cardiomyopathy (ICM), recurrent VF may be treated with catheter ablation by targeting triggering premature ventricular complexes (PVCs) and/or ventricular scar homogenization. Data on optimal ablation strategies in patients with non‐ischemic cardiomyopathy (NICM) remain limited.
Kenji Hashimoto +2 more
wiley +1 more source
Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock.
IntroductionThe prevalence of hypoalbuminemia, early changes of plasma albumin (P-Alb) levels, and their effects on mortality in cardiogenic shock are unknown.Materials and methodsP-Alb was measured from serial blood samples in 178 patients from a ...
Toni Jäntti +16 more
doaj +1 more source
Safety and Efficacy of Right‐ Versus Left‐Sided Transvenous Lead Extraction
ABSTRACT Background and Aims Transvenous lead extraction (TLE) is increasingly performed for malfunction or infection of cardiac implantable electronic devices. Because of anatomic differences, TLE for right‐sided (RS) electrodes may differ in outcome. This study aimed to evaluate whether RS TLE differs in patient characteristics and outcomes compared ...
Nadine Molitor +5 more
wiley +1 more source
Among 8,779 non‐diabetic patients with first‐onset STEMI, older age was associated with a higher likelihood of stress hyperglycemia. However, the excess mortality risk associated with stress hyperglycemia was greatest in younger patients and attenuated with advancing age, highlighting the possibility of age‐dependent prognostic significance.
Hon Jen Wong +22 more
wiley +1 more source
Definitions and Treatment of Pulseless Electrical Activity, Pseudo-Pulseless Electrical Activity and Cardiogenic Shock: A Retrospective Video-Based Analysis [PDF]
Objective: Cardiopulmonary arrest (CPA) rhythms are classified into shockable and non-shockable categories. Pulseless electrical activity (PEA) is a non-shockable rhythm defined as the absence of a palpable pulse despite organized electrical activity on ...
Serkan Bilgin +5 more
core +1 more source

